null

DiMethyl-Histone H3-K14 Rabbit Polyclonal Antibody (CAB5278)

SKU:
CAB5278
Product Type:
Antibody
Applications:
WB
IHC
IF
IP
ChIP
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K14 Antibody CAB5278
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K14 Antibody CAB5278
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K14 Antibody CAB5278
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K14 Antibody CAB5278
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-DiMethyl-Histone H3-K14 Antibody CAB5278
€139 - €419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

DiMethyl-Histone H3-K14 Rabbit Polyclonal Antibody (CAB5278)

The Dimethyl-Histone H3 (K14) Polyclonal Antibody (CAB5278) is a valuable tool for researchers studying histone modifications and their impact on gene expression regulation. This antibody, raised in rabbits, specifically targets the dimethylated form of Histone H3 at lysine 14, a key modification associated with transcriptional activation and chromatin accessibility.Validated for use in various applications, including Western blotting and immunofluorescence, this antibody allows for the detection and analysis of dimethyl-Histone H3 (K14) in a variety of cell types and experimental conditions. Its high reactivity with human samples makes it an ideal reagent for studies investigating epigenetic mechanisms in cancer, development, and other biological processes.

Understanding the role of histone modifications, such as dimethylation of Histone H3 at lysine 14, is essential for unraveling the complex regulatory networks that control gene expression and cellular function. By utilizing this antibody, researchers can gain valuable insights into the molecular mechanisms governing chromatin dynamics and epigenetic regulation, paving the way for novel therapeutic approaches in various disease contexts.